Journals / Turkish Journal of Medical Sciences / 2022 / Cilt: 52 - Sayı: 1

Developing the Nausea and Vomiting Thermometer Scale in children with cancer

Pages
166–174
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The NVTS was found to be a valid and reliable measurement tool for children with cancer in the Turkish sample.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: This study aimed to develop the Nausea and Vomiting Thermometer Scale (NVTS) in children with cancer.
📊
Key Findings & Data:Materials and methods: This methodological study was conducted on 250 children with cancer at the research and training university hospital in Turkey between September 2019 and January 2020.
💡
Conclusion & Impact:Conclusion: The NVTS was found to be a valid and reliable measurement tool for children with cancer in the Turkish sample.
🔬Design:Modeling & Simulation
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: This study aimed to develop the Nausea and Vomiting Thermometer Scale (NVTS) in children with cancer. Materials and methods: This methodological study was conducted on 250 children with cancer at the research and training university hospital in Turkey between September 2019 and January 2020. The t-test, the ROC analysis, the Diagnostic index, and the Youden index were used for determining the scale of the cutting point. The regression analysis, the intra-class correlation coefficient, and the Bland– Altman analysis were used for the data analysis. Results: The scale-level content validity index was .94, which was coherent. As a result of the ROC analysis, the cut-off point was determined as three points. The NVTS showed good reliability, with an intra-class correlation coefficient of .99. In the linear regression analysis, a model was created for chemotherapy drugs, nausea and vomiting type, vomiting status, and the number of children with cancer who vomited explained 44.9% of their nausea and vomiting status. The results of the Bland–Altman analysis showed that the correlation coefficient between the differences and the means was insignificant. Conclusion: The NVTS was found to be a valid and reliable measurement tool for children with cancer in the Turkish sample.

🔖

Cite This Article

KUDUBEŞ, A. A., BEKTAŞ, M. (2022). Developing the Nausea and Vomiting Thermometer Scale in children with cancer. Turkish Journal of Medical Sciences, Cilt: 52 - Sayı: 1, 166–174. https://ajindex.com/articles/609291

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Miller E, Jacob E, Hockenberry MJ. Nausea, pain, fatigue, and multiple symptoms in hospitalized children with cancer. Oncology Nursing Forum 2011
  2. 382–393. doi: 10.1188/11. ONF.E382-E393 2. Rodgers C, Hooke MC, Ward J, Linder LA. Symptom clusters in children and adolescents with cancer. Seminars in Oncology Nursing 2016
  3. doi: 10.1016/j.soncn.2016.08.005 3. Esenay FI, Sezer TA, Turan SA. Causal perceptions in Turkish parents of children with cancer (article in Turkish with an abstract in English). Turkish Journal of Oncology 2018
  4. doi: https://doi.org/10.5505/tjo.2018.1788 4. Jordan K, Roila F, Molassiotis A, Maranzano E, Clark-Snow RA et al. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009. Supportive Care in Cancer 2011
  5. doi: https://doi.org/10.1007/s00520- 010-0994-7 5. Rodgers C, Kollar D, Taylor O, Bryant R, Crockett K et al. Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment. Cancer Nursing 2012
  6. doi: https://doi.org/10.1097/ NCC.0b013e3182281493 6. Flank J, Robinson PD, Holdsworth M, Phillips R, Portwine C et al. Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy-induced nausea and vomiting in children with cancer. Pediatric Blood & Cancer 2016
  7. doi.https://doi.org/10.1002/pbc.25955 7. Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ et al. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology 2016
  8. v119-133. doi: https:// doi.org/10.1093/annonc/mdw270 8. Dupuis LL, Taddio A, Kerr EN, Kelly A, MacKeigan L. Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents. Pharmacotherapy 2006
  9. doi: https://doi. org/10.1592/phco.26.9.1221 9. Patel GS, Jain K, Kumar R, Strickland AH, Pellegrini L et al. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted portchamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Supportive Care in Cancer 2014
  10. doi: https://doi. org/10.1007/s00520-013-1941-1 10. Velez-Florez G, Velez-Florez MC, Mantilla-Rivas JO, Patarroyo-Rodríguez L, Borrero-León R et al. Mind-body therapies in childho